81 Patients Found New Answers Through Reanalysis of Genetic Testing: April 2026

Is a single genetic test result the end of the diagnostic journey?
At 3billion, we believe diagnosis is an ongoing process. That’s why we focus not only on the test itself, but on what comes after:
Reanalysis.
For all cases previously reported as Inconclusive or Negative,
3billion performs automated reanalysis through a continuous system.
Each month, dozens of reports are updated, revealing new diagnostic insights and possibilities.
Summary of Diagnostic Changes This Month

In April 2026, a total of 81 patients received updated reports through reanalysis.
Why did the results change?

54%: Variant database updates
30%: Disease database updates
11%: Algorithm improvement
4%: Additional clinical or phenotype data
1%: Segregation analysis
This means that as clinical and scientific data evolve, the same patient data can lead to a different diagnosis over time.
A reanalysis system is essential for keeping pace with constantly evolving databases. 3billion automates this process to deliver results faster and at a more accessible cost.
So, how exactly does automated reanalysis work?
It continuously monitors the latest variant and disease databases, updates internal interpretation models, and incorporates new phenotype and family history data submitted by clinicians.
Diagnosis doesn’t end with a single report.
It continues as the knowledge base grows— and 3billion’s automated reanalysis system ensures patients benefit from that progress.
Get exclusive rare disease updates
from 3billion.

Soo-jung Baek
As a marketer, I strive to empower the rare disease community by sharing meaningful insights backed by our company’s expertise.





